慢性心力衰竭治療的現(xiàn)狀(5)
所有瓣膜疾病的心衰患者,均需對(duì)是否適合手術(shù)治療作出評(píng)定。
氧氣療法[5]:與傳統(tǒng)的觀念相反,氧療對(duì)慢性心衰患者并無(wú)應(yīng)用指征。更有報(bào)告在重度心衰患者,氧療反使血液動(dòng)力學(xué)惡化。
運(yùn)動(dòng)[10]:以往主張限制心衰患者的運(yùn)動(dòng),但長(zhǎng)期臥床的去適應(yīng)狀態(tài)對(duì)患者不利。現(xiàn)今的觀點(diǎn)是:應(yīng)鼓勵(lì)患者作動(dòng)態(tài)運(yùn)動(dòng)。有證據(jù)表明,穩(wěn)定性心衰患者,運(yùn)動(dòng)鍛煉可提高運(yùn)動(dòng)耐量和生活質(zhì)量,對(duì)預(yù)后的影響尚不肯定。有人認(rèn)為,運(yùn)動(dòng)訓(xùn)練可作為一種新的治療方法。
參考文獻(xiàn)
1.Cohn JN. Struuctural changes in cardiovascular disease. Am J Cardiol, 1995,76:34-37.
2.Cohn JN. Structural basis for heart failure. Circulation, 1995,91:2504-2507
3.Katz AM. Regression of left ventricular hypertrophy: new hope for dying hearts. Circulation, 1998,98:623-624.
4.ACC/AHA Task Force Report. Guidelines for the evaluation and managerment of heart failure. JACC, 1995,26:1376-1398.
5.The task force of the working group on heart failure of the European society of cardiogy: the treatment of heart failure.Heart J, 1997,18:736-753.
6.Advisory Council to Improve Outcomes Nationwide in Heart Failure. Consensus recommendations for the management of chronic heart failure. Am J Cardiol, 1999,83:1-30.
7.Dangas G, Gorlin R. The role of digitalis in the management of heart failure: old molecule new respectability. In: coats A(ed). Coutroversies in the management of heart failure. London: Churchill Livingstone, 1997.83-96.
8.Cleland JGF, McGowan J, Clark A. The evidence for β blockers in heart failure. BMJ, 1999, 318:824-825.
9.Struthers AD. Aldosterone escape during ACE inhibitor therapy in chronic heart failure. Eur Heart J, 1995,16(Suppl N):103-106
10.Clark AL. Exercise therapy in chronic heart failure-a novel management approach. In: Coats A(ed). Cotroversies in the management of heart failure. London: Churchill Livingstone,1997.157-171, http://www.www.srpcoatings.com(戴閨柱)
氧氣療法[5]:與傳統(tǒng)的觀念相反,氧療對(duì)慢性心衰患者并無(wú)應(yīng)用指征。更有報(bào)告在重度心衰患者,氧療反使血液動(dòng)力學(xué)惡化。
運(yùn)動(dòng)[10]:以往主張限制心衰患者的運(yùn)動(dòng),但長(zhǎng)期臥床的去適應(yīng)狀態(tài)對(duì)患者不利。現(xiàn)今的觀點(diǎn)是:應(yīng)鼓勵(lì)患者作動(dòng)態(tài)運(yùn)動(dòng)。有證據(jù)表明,穩(wěn)定性心衰患者,運(yùn)動(dòng)鍛煉可提高運(yùn)動(dòng)耐量和生活質(zhì)量,對(duì)預(yù)后的影響尚不肯定。有人認(rèn)為,運(yùn)動(dòng)訓(xùn)練可作為一種新的治療方法。
參考文獻(xiàn)
1.Cohn JN. Struuctural changes in cardiovascular disease. Am J Cardiol, 1995,76:34-37.
2.Cohn JN. Structural basis for heart failure. Circulation, 1995,91:2504-2507
3.Katz AM. Regression of left ventricular hypertrophy: new hope for dying hearts. Circulation, 1998,98:623-624.
4.ACC/AHA Task Force Report. Guidelines for the evaluation and managerment of heart failure. JACC, 1995,26:1376-1398.
5.The task force of the working group on heart failure of the European society of cardiogy: the treatment of heart failure.Heart J, 1997,18:736-753.
6.Advisory Council to Improve Outcomes Nationwide in Heart Failure. Consensus recommendations for the management of chronic heart failure. Am J Cardiol, 1999,83:1-30.
7.Dangas G, Gorlin R. The role of digitalis in the management of heart failure: old molecule new respectability. In: coats A(ed). Coutroversies in the management of heart failure. London: Churchill Livingstone, 1997.83-96.
8.Cleland JGF, McGowan J, Clark A. The evidence for β blockers in heart failure. BMJ, 1999, 318:824-825.
9.Struthers AD. Aldosterone escape during ACE inhibitor therapy in chronic heart failure. Eur Heart J, 1995,16(Suppl N):103-106
10.Clark AL. Exercise therapy in chronic heart failure-a novel management approach. In: Coats A(ed). Cotroversies in the management of heart failure. London: Churchill Livingstone,1997.157-171, http://www.www.srpcoatings.com(戴閨柱)
百拇醫(yī)藥網(wǎng) http://www.www.srpcoatings.com/html/Dir/2003/09/26/99/274.htm